NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Gerard Fox
AbbVie Inc - Chicago / United States
Others
AD Scientific Index ID: 4399868
-
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Gerard Fox's MOST POPULAR ARTICLES
1-)
Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injuryAG Yakovlev, SM Knoblach, L Fan, GB Fox, R Goodnight, AI FadenJournal of Neuroscience 17 (19), 7415-7424, 19977441997
2-)
Sustained sensory/motor and cognitive deficits with neuronal apoptosis following controlled cortical impact brain injury in the mouseGB FOX, LEI Fan, RA LEVASSEUR, AI FADENJournal of neurotrauma 15 (8), 599-614, 19983531998
3-)
Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl] ethyl}-benzofuran-5-yl) benzonitrile]: II. Neurophysiological characterization and broad preclinical …GB Fox, TA Esbenshade, JB Pan, RJ Radek, KM Krueger, BB Yao, ...Journal of Pharmacology and Experimental Therapeutics 313 (1), 176-190, 20052862005
4-)
Histamine H3 receptor antagonists: preclinical promise for treating obesity and cognitive disordersTA Esbenshade, GB Fox, MD CowartMolecular interventions 6 (2), 77, 20062192006
5-)
Effects of histamine H3 receptor ligands GT-2331 and ciproxifan in a repeated acquisition avoidance response in the spontaneously hypertensive rat pupGB Fox, JB Pan, TA Esbenshade, YL Bennani, LA Black, R Faghih, ...Behavioural brain research 131 (1-2), 151-161, 20021852002
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept